Sanofi avoids EU fine after concessions end rival flu vaccine probe
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
EU regulators ended an antitrust investigation without fining Sanofi after it agreed to correct claims that allegedly disparaged CSL Seqirus’s Fluad vaccine in Germany and France. Sanofi must run a corrective campaign and refrain from similar conduct under a legally binding agreement.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu